A carregar...
Return to Intended Oncologic Treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy
BACKGROUND: After cancer surgery, complications and disability prevent some patients from receiving subsequent treatments. Given that an inability to complete all intended cancer therapies may negate the oncologic benefits of surgical therapy, strategies to improve Return to Intended Oncologic Treat...
Na minha lista:
| Publicado no: | J Surg Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527828/ https://ncbi.nlm.nih.gov/pubmed/24846705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.23626 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|